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Tropism for microvascular endothelium is a
unique and poorly understood aspect of rickett-
sioses in humans and in laboratory animal models
of infection. In vitro ﬁndings from our laboratory
suggest that Rickettsia rickettsii infection results in
robust modulation of various host cell defence
mechanisms and signalling pathways in human
primary umbilical vein endothelial cells (HU-
VECs), including: (i) activation of nuclear tran-
scription factor NF-jB and a family of
serine ⁄ threonine protein kinases, namely p38
mitogen-activated protein (MAP) kinase [1,2];
and (ii) induced expression of antioxidant and
vasoprotective enzyme heme oxygenase-1 (HO-1)
and inducible isoform of cyclooxygenase - COX-2
[3,4].
HO, the initial rate-limiting enzyme in the
pathway for heme catabolism, plays a vital role
in oxidative biotransformation. The inducible
isozyme HO-1 serves as a key stress response
protein in a variety of cells against a plethora of
stimuli. R. rickettsii infection of HUVECs induces
HO-1 expression at the level of transcription as
well as protein synthesis [3]. One of the critical
regulatory functions of HO-1 in the vasculature is
to control the activity of the COX system, which is
responsible for the generation of a number of
vasoactive substances including prostaglandins.
Of the known COX isoforms, COX-2 is extremely
sensitive to a variety of stimuli, including host cell
interactions with pathogenic viruses and bacteria.
In R. rickettsii-infected HUVECs, changes in COX-
2 expression apparently follow a biphasic pattern
of induction with mRNA expression peaks at 3
and 21 h post-infection, which differs from the
kinetics of the HO-1 response. Furthermore,
transcriptional activation of COX-2 occurs
through signalling from the p38 MAP kinase
module and in turn, stimulates prostaglandin
release by R. rickettsii-infected HUVECs [4].
In the present study, we have investigated the
regulation of host cell defence mechanisms
during R. rickettsii infection of primary human
pulmonary microvascular endothelial cells
(HPMECs) and compared the response(s) with
those with macrovascular HUVECs, an estab-
lished model cell type for in vitro infection.
HPMECs were purchased from ScienCell
Research Laboratories (San Diego, CA, USA).
Viability of R. rickettsii (Sheila Smith strain)
preparations was determined by plaque assay as
previously described [3] and conﬁrmed by
Taqman(Applied Biosystems Inc., Foster City,
CA, USA)-based quantitative PCR using primer
pair Rp877p-Rp1258n for the rickettsial citrate
synthase gene [5] and an internal probe with
100% homology for R. rickettsii. Infection of
HPMECs and HUVECs was carried out as previ-
ously described [1–4]. The mRNA and protein
expression for HO-1 and COX-2 were analysed by
Northern and Western hybridisation protocols
described earlier [3,4]. Prostaglandin contents
in culture supernatants were determined by
competitive ELISA [4].
Comparative analysis of HO-1 expression dur-
ing R. rickettsii infection revealed nearly identical
patterns of increased steady-state HO-1 mRNA in
HPMECs and HUVECs. Similar to HUVECs [3],
HPMECs also demonstrated increased HO-1
expression in response to R. rickettsii infection
with maximum response of one- to three-fold
induction over basal expression at 7 h post-infec-
tion (not shown). Transcriptional activation of
COX-2 in HPMECs infected with R. rickettsii also
displayed dynamics apparently similar to that
seen in HUVECs (Fig. 1a). A biphasic response
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with the ﬁrst peak at 3–7 h (9.7-fold over base-
line), followed by a later peak at 24 h post-
infection (6.1-fold higher than the corresponding
control) was evident (Fig. 1b), but its level at 7 h
was dramatically lower than in HUVECs under
the same infection conditions (Fig. 1a). This may
be due to striking differences in the basal level for
COX-2 expression in HPMECs, which is consid-
erably lower than in HUVECs (Fig. 1a). Conse-
quently, steady-state levels of COX-2 protein in
R. rickettsii-infected HPMECs were also signiﬁ-
cantly lower than in HUVECs (Fig. 1c,d).
In comparison with HUVECs, R. rickettsii
infection of HPMECs also resulted in very low
secretion levels of prostaglandins PGE2 and
6-keto-PGF1a as expected. The average concentra-
tion of PGE2 in medium samples from uninfected
HPMECs was 0.13 ng ⁄mL. The PGE2 content in
culture medium from R. rickettsii-infected
HPMECs at 3, 6, 12 and 24 h post-infection was
measured at 0.15, 0.32, 0.41 and 0.25 ng ⁄mL,
respectively. For 3 and 24 h, these values were
about 20 and 80 times lower when compared
directly with HUVECs’ response [4]. The basal
level of 6-keto-PGF1a secretion by HPMECs under
culture conditions used in this study was
4.4 ng ⁄mL. During R. rickettsii infection, how-
ever, 6-keto-PGF1a levels in the culture medium
increased to 6.8, 9.7, 9.2 and 11.0 ng ⁄mL at 3, 6, 12
and 24 h. Interestingly, although the basal level of
6-keto-PGF1a for HUVECs was very similar
(3.7 ng ⁄mL) to that of HPMECs, its secretion was
found to increase steadily from 7.2 ng ⁄mL at 3 h
to 68.2 ng ⁄mL at 18 h. Comparatively lower levels
of COX-2 transcriptional activation, protein syn-
thesis and subsequent prostaglandin release by
pulmonary microvascular endothelial cells sup-
port the concept of endothelial heterogeneity and
may yield useful clues for better understanding of
rickettsial tropism for microvascular endothelium.
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Fig. 1. Analysis of transcriptional activation and protein synthesis of COX-2 in HPMECs infected with Rickettsia rickettsii.
(a) Representative Northern blot from human pulmonary microvascular endothelial cells (HPMECs) infected with
Rickettsia rickettsii (Rr) for different durations or uninfected cells (Control). Blots were hybridised with 32P-labelled speciﬁc
COX-2 cDNA probe followed by the same for GAPDH to adjust for loading variations. RNA isolated from human
umbilical vein endothelial cells (HUVECs) infected with Rr for 7 h was included as a positive control. (b) Band intensities
were determined and normalised using GAPDH as housekeeping gene. Fold induction over the average baseline value
was calculated and compared with similar data from Rr-infected HUVECs. (c) Representative Western blot of total cell
lysates from HPMECs infected with Rr for different lengths of time and simultaneously processed uninfected cells
(Control). HUVECs infected with Rr and corresponding uninfected controls were included for comparison. Membrane was
immunoblotted with a COX-2-speciﬁc antibody and then reprobed for a-tubulin to control for protein loading. (d) The
basal level of COX-2 protein in control samples was assigned a value of 1. Fold induction over the average baseline value
was calculated and compared with similar data for Rr-infected HUVECs.
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